Founded with the mission to revolutionize drug discovery, CytoTronics leverages its proprietary complementary metal-oxide-semiconductor (CMOS) electronics platform to enable optics-free imaging. The company's core vision is to provide high-throughput, single-cell resolution insights into cell functions, thereby accelerating the drug discovery process. Their flagship product, Pixel™, integrates cutting-edge technology with live-cell biology and data science, offering multiplexed live-cell readouts that seamlessly integrate with other systems and scale efficiently with cloud services.
CytoTronics has garnered attention within the scientific community, evidenced by their Pixel™ system receiving the New Product Award from the Society for Laboratory Automation and Screening (SLAS). This recognition underscores the innovative impact of their technology. By eliminating the need for traditional optics in imaging, CytoTronics has significantly advanced the capabilities of cellular analysis, positioning itself as a key player in the biotechnology and pharmaceutical industries.
